pubmed-article:18661495 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0007559 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0746883 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0250480 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0246584 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
pubmed-article:18661495 | lifeskim:mentions | umls-concept:C1880496 | lld:lifeskim |
pubmed-article:18661495 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:18661495 | pubmed:dateCreated | 2008-10-15 | lld:pubmed |
pubmed-article:18661495 | pubmed:abstractText | The aim of this randomized study was to evaluate the efficacy of cefozopran monotherapy and piperacillin-tazobactam plus ceftazidime (PIPC/TAZ + CAZ) combination therapy in pediatric neutropenic patients. | lld:pubmed |
pubmed-article:18661495 | pubmed:language | eng | lld:pubmed |
pubmed-article:18661495 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18661495 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18661495 | pubmed:month | Dec | lld:pubmed |
pubmed-article:18661495 | pubmed:issn | 1545-5017 | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:KobayashiKuni... | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:KobayashiRyoj... | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:SatoTomonobuT | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:KanedaMakotoM | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:IguchiAkihiro... | lld:pubmed |
pubmed-article:18661495 | pubmed:author | pubmed-author:YasudaKazueK | lld:pubmed |
pubmed-article:18661495 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18661495 | pubmed:volume | 51 | lld:pubmed |
pubmed-article:18661495 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18661495 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18661495 | pubmed:pagination | 774-7 | lld:pubmed |
pubmed-article:18661495 | pubmed:dateRevised | 2009-1-12 | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:meshHeading | pubmed-meshheading:18661495... | lld:pubmed |
pubmed-article:18661495 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18661495 | pubmed:articleTitle | A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. | lld:pubmed |
pubmed-article:18661495 | pubmed:affiliation | Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan. t-satou@jacls.jp | lld:pubmed |
pubmed-article:18661495 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18661495 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:18661495 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:18661495 | pubmed:publicationType | Multicenter Study | lld:pubmed |